BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22192452)

  • 1. Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria.
    Aibinu I; Odugbemi T; Koenig W; Ghebremedhin B
    Clin Microbiol Infect; 2012 Mar; 18(3):E49-51. PubMed ID: 22192452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt.
    Hassan WM; Hashim A; Domany R
    Indian J Med Microbiol; 2012; 30(4):442-7. PubMed ID: 23183470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil.
    Peirano G; Asensi MD; Pitondo-Silva A; Pitout JD
    Clin Microbiol Infect; 2011 Jul; 17(7):1039-43. PubMed ID: 21722255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.
    Oteo J; Diestra K; Juan C; Bautista V; Novais A; Pérez-Vázquez M; Moyá B; Miró E; Coque TM; Oliver A; Cantón R; Navarro F; Campos J;
    Int J Antimicrob Agents; 2009 Aug; 34(2):173-6. PubMed ID: 19464856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
    Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
    J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of blaCTX-M IncFII plasmids and clones of Escherichia coli from pets in France.
    Dahmen S; Haenni M; Châtre P; Madec JY
    J Antimicrob Chemother; 2013 Dec; 68(12):2797-801. PubMed ID: 23852541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-ST131 Escherichia coli from cattle harbouring human-like bla(CTX-M-15)-carrying plasmids.
    Madec JY; Poirel L; Saras E; Gourguechon A; Girlich D; Nordmann P; Haenni M
    J Antimicrob Chemother; 2012 Mar; 67(3):578-81. PubMed ID: 22210752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.
    Mora A; Blanco M; López C; Mamani R; Blanco JE; Alonso MP; García-Garrote F; Dahbi G; Herrera A; Fernández A; Fernández B; Agulla A; Bou G; Blanco J
    Int J Antimicrob Agents; 2011 Jan; 37(1):16-21. PubMed ID: 21075606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
    J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
    Peirano G; van Greune CH; Pitout JD
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):449-53. PubMed ID: 21396544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131.
    Kuroda H; Yano H; Hirakata Y; Arai K; Endo S; Kanamori H; Yamamoto H; Ichimura S; Ogawa M; Shimojima M; Komatsu M; Jonai T; Itagaki S; Nonomiya Y; Suwabe A; Kaku M
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):201-3. PubMed ID: 22796185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
    Suzuki S; Shibata N; Yamane K; Wachino J; Ito K; Arakawa Y
    J Antimicrob Chemother; 2009 Jan; 63(1):72-9. PubMed ID: 19004839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania.
    Mshana SE; Imirzalioglu C; Hain T; Domann E; Lyamuya EF; Chakraborty T
    Clin Microbiol Infect; 2011 Aug; 17(8):1279-82. PubMed ID: 21595794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.
    Seiffert SN; Hilty M; Kronenberg A; Droz S; Perreten V; Endimiani A
    J Antimicrob Chemother; 2013 Oct; 68(10):2249-54. PubMed ID: 23759671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.